Jul 7, 2009 by Brian Orelli, PhDGlaxo Missed the BoatThe HPV vaccine market is declining before Glaxo can hop aboard.
Jul 6, 2009 by Brian Orelli, PhDThe Wrong Way to Invest in the Right StocksExchange-traded funds don't work for this industry.
Jul 2, 2009 by Brian Orelli, PhDSqueezing Blood From a Half-Dollar Desperate times don't play well for deal making.
Jun 30, 2009 by Brian Orelli, PhDFollowing the Pack to Future ReturnsMylan's playing catch up, but there's room for more.
Jun 30, 2009 by Brian Orelli, PhDOne-Drug Wonders Deserve a Spot in Your PortfolioLooking a little more appetizing these days.
Jun 29, 2009 by Brian Orelli, PhDYour Company Has Been Raided. What Now?Is the FDA after your company?
Jun 29, 2009 by Brian Orelli, PhDGilead Says "Pleeeease." EU Says "Well, OK."An appeal that actually resulted in an approved drug.
Jun 29, 2009 by Brian Orelli, PhDLantus Results: Reply Hazy, Try Again LaterDrugmaker Sanofi's problems become murkier.
Jun 29, 2009 by Brian Orelli, PhDFunding From an Unlikely PlaceDrug companies get help from nonprofits.
Jun 29, 2009 by Brian Orelli, PhDREMS: Not Just for Sleeping AnymoreTurning a governmental requirement into a strength.
Jun 26, 2009 by Brian Orelli, PhDThe $16 Billion Market That Could Make You RichA large market just waiting to be taken over.
